Charles River Laboratories
Flavia Pease serves as the Chief Financial Officer at Charles River Laboratories since April 2022, bringing extensive financial leadership experience from their previous roles at Johnson & Johnson. At Johnson & Johnson, Flavia held various significant positions, including VP/Group CFO of Medical Devices, where responsibilities included overseeing global finance for the medical device businesses, and Vice President Finance for the North America Pharmaceutical Division, managing finance support for North American operations. Flavia also served as Chief of Staff to the CEO, overseeing strategic initiatives and portfolio management, and held finance leadership roles across different sectors of the company, including the supply chain and mergers and acquisitions. Prior to joining Johnson & Johnson, Flavia held finance positions at Acclarent, Mentor Worldwide LLC, and LifeScan. Flavia holds a BS in Economics from PUC-Rio and an MBA in Finance and International Business from Santa Clara University.
This person is not in any teams
This person is not in any offices
Charles River Laboratories
15 followers
Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. The Company operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment includes Research Models and Research Model Services. The DSA segment includes Discovery Services and Safety Assessment. The Manufacturing segment includes Microbial Solutions, Avian, Biologics and Contract Manufacturing. The Company also provides a suite of products and services to support the Company's clients' manufacturing activities.